CPIX News and Press, Cumberland Pharmaceuticals Inc. From 03/03/26

2026-03-03 19:33:17 ET More on Cumberland Pharmaceuticals Cumberland Pharmaceuticals Inc. (CPIX) Q4 2025 Earnings Call Prepared Remarks Transcript Seeking Alpha’s Quant Rating on Cumberland Pharmaceuticals Financial information for Cumberland Pharmaceuticals ...

2026-03-03 17:45:20 ET Image source: The Motley Fool. Tuesday, March 3, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-03-03 17:11:38 ET More on Cumberland Pharmaceuticals Seeking Alpha’s Quant Rating on Cumberland Pharmaceuticals Financial information for Cumberland Pharmaceuticals Read the full article on Seeking Alpha For further details see: Cumberland Pha...

CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH PR Newswire Cumberland to highlight 2025 financial, international, portfolio and clinical progress NASHVILLE, Tenn. , March 3, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a spe...

2026-03-02 17:33:37 ET Cumberland Pharmaceuticals Inc. (CPIX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CPIX stock price following earnings has averaged ±5.23% , with a median of...

Joint U.S. Commercialization of RedHill's Talicia® Commences PR Newswire The full sales and operational launch of Talicia, under the joint commercialization agreement between Talicia Holdings Inc. (THI), a jointly controlled entity of RedHill and Cumberland has started and is ...

CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA® PR Newswire NASHVILLE, Tenn. , Feb. 25, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused on developing new products for rare diseases, today a...

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE, Tenn. , Feb. 24, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nas...

2026-02-17 09:40:38 ET Short sellers are largely absent from a group of small- and mid-cap stocks where short interest hovers around just 0.5%, signaling limited bearish conviction across a diverse mix of sectors.... Read the full article on Seeking Alpha For further details see...

Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program PR Newswire NASHVILLE, Tenn. , Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused o...